Citius Oncology CTOR
NASDAQ CTOR
$0.56 0.00 (-0.71%)
As of: Nov 11, 2026 · 3:59 PM EST

Citius Oncology (CTOR) Change in Other Operating Assets (2023 - 2026)

Updated

Citius Oncology's Change in Other Operating Assets was -$221,107 in fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Citius Oncology (CTOR) Change in Other Operating Assets (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Citius Oncology's Change in Other Operating Assets was $1.48 million through Jun 30, 2026; for FY2024 (ended Sep 30, 2024), it came in at $1.1 million.

  • In earlier fiscal years, Change in Other Operating Assets was -$62,715 in FY2023 and $88,169 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -122.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -251.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 32.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Citius Oncology 60.42 Mn 30.00 Mn 1.00 Mn -221,107.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -221,107.00
Mar 31, 2026 -110,553.00
Dec 31, 2025 1.83 Mn
Jun 30, 2024 -20,338.00
Mar 31, 2024 35,610.00
Jun 30, 2023 -33,178.00
Mar 31, 2023 36,821.00
API Access

Citius Oncology Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=CTOR&period=max&api_key=YOUR_API_KEY